Hong Kong Engagement Series
Friday 2 February 2024, 7.00pm to 8.30pm HKT
Hong Kong Engagement Series
Friday, 2 February 2024 - 7.00pm - 8.30pm HKT
Hong Kong Club
The University of Cambridge has a centuries-old history of partnership with Hong Kong, with an outstanding track record of Chinese students coming to Cambridge for undergraduate, post-graduate and medical studies, creating a global network. Now, a new chapter in this collaboration is beginning through the planned Cambridge Children’s Hospital.
While approximately 75 per cent of adult mental health issues originate during childhood and adolescence, how do we best tackle this far-reaching and global problem? Indeed, can we treat illness better, through early detection of disease origins?
Cambridge is undertaking world-leading research into how to fully integrate body and mind health and research to establish root causes of disease, provide more comprehensive support for children, young people and their families, and ultimately improve outcomes across the life span. The Cambridge Children's Hospital will be the hub of this work, delivering important new advances in holistic healthcare and bringing exciting opportunities to talented young Chinese students and trainees.
Join Professor David Rowitch FMedSci FRS, Head of the Department of Paediatrics at Cambridge, as he discusses the global future of research, genomics and clinical care for children and young people with physical and mental health conditions, and the far-reaching impact of the Cambridge model.
This event is part of the Hong Kong Engagement Series; you can read more about the series and the Host Committee on the series homepage.
David Rowitch
David Rowitch is a pediatrician (neonatology) and developmental neuroscientist. He is Professor and Head of Department of Paediatrics at the University of Cambridge (UK), and Adjunct Professor of Pediatrics at University of California San Francisco. He obtained his MD from University of California Los Angeles and PhD (biochemistry) from the University of Cambridge.
Professor Rowitch’s laboratory in the Wellcome-MRC Cambridge Stem Cell Institute investigates genetic factors that determine development and diversity of glia, which comprise 90% of cells in the human brain. He has applied principles of developmental neuroscience to better understand human neonatal brain development as well as white matter injury in premature infants, multiple sclerosis and leukodystrophy.
As a physician-scientist, Professor Rowitch’s interest focuses on functional genomic technologies to better diagnose and treat rare neurogenetic disorders in children. He is academic lead for the new Cambridge Children’s Hospital, researching origins of paediatric physical and mental conditions and preventive interventions within the UK National Health Service.
His research in the field of developmental neurobiology and biomedicine has earned him numerous awards, including election as Fellow of the Academy Medical Sciences (UK) in 2018 and Fellow of the Royal Society in 2021.
Dr Lucy Lord (Downing 1981, Clinical Medicine)
Dr Lucy Lord is an Obstetrician and Gynaecologist and the founding Partner of Central Health Medical Group. She relocated to Hong Kong from the UK in 1989 as a Lecturer in Obstetrics and Gynaecology at the University of Hong Kong, and started working in private practice in 1991. Lucy set up the Patient Care Foundation (PCF), Central Health’s charitable foundation, which works to provide vulnerable, stigmatised or deprived groups and communities within Hong Kong with better access to medical care. She founded and is Co-Chair of Mind HK, and was also instrumental in the founding of the City Mental Health Alliance in Hong Kong.
Booking information
Booking for this event is now closed.
